Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Liabilities and Shareholders Equity (2016 - 2026)

Conmed filings provide 17 years of Liabilities and Shareholders Equity readings, the most recent being $2.3 billion for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 0.75% to $2.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $9.3 billion, a 0.94% increase, with the full-year FY2025 number at $2.3 billion, up 0.85% from a year prior.
  • Liabilities and Shareholders Equity hit $2.3 billion in Q1 2026 for Conmed, roughly flat from $2.3 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.3 billion in Q2 2025 to a low of $1.8 billion in Q1 2022.
  • Median Liabilities and Shareholders Equity over the past 5 years was $2.3 billion (2024), compared with a mean of $2.3 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 30.67% in 2022 and later decreased 1.6% in 2024.
  • Conmed's Liabilities and Shareholders Equity stood at $2.3 billion in 2022, then increased by 0.11% to $2.3 billion in 2023, then increased by 0.27% to $2.3 billion in 2024, then increased by 0.85% to $2.3 billion in 2025, then fell by 0.46% to $2.3 billion in 2026.
  • The last three reported values for Liabilities and Shareholders Equity were $2.3 billion (Q1 2026), $2.3 billion (Q4 2025), and $2.3 billion (Q3 2025) per Business Quant data.